Tina Kottek

Tina Kottek

Auto-generated profile, based on publicly available information

Tina Kottek

Department of Cranio Maxillofacial Surgery, University Clinic Leipzig, Liebigstr. 12, Leipzig 04103, Germany

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in BioMed Research International
Verified
Journal Article
Open access
PDF file
SGSebastian Gaus
Sebastian Gaus
HLHanluo Li
Hanluo Li
Simin LiSimin Li
Simin Li
QWQian WANG
Qian WANG
TKTina Kottek
Tina Kottek
BLBernd Lethaus
Bernd Lethaus
Objective. To identify the shared genetic and epigenetic mechanisms between the osteogenic differentiation of dental pulp stem cells (DPSC) and bone marrow stem cells (BMSC). Materials and Methods. The profiling datasets of miRNA expression in the osteogenic differentiation of mesenchymal stem cells from the dental pulp (DPSC) and bone marrow (BMSC) were searched in the Gene Expression Omnibus (GEO) database. The differential expression analysis was performed to identify differentially expressed miRNAs (DEmiRNAs) dysregulated in DPSC and BMSC osteodifferentiation. The target genes of the DEmiRNAs that were dysregulated in DPSC and BMSC osteodifferentiation were identified, followed by the identification of the signaling pathways and biological processes (BPs) of these target genes. Accordingly, the DEmiRNA‐transcription factor (TFs) network and the DEmiRNAs‐small molecular drug network involved in the DPSC and BMSC osteodifferentiation were constructed. Results. 16 dysregulated DEmiRNAs were found to be overlapped in the DPSC and BMSC osteodifferentiation, including 8 DEmiRNAs with a common expression pattern (8 upregulated DEmiRNAs (miR‐101‐3p, miR‐143‐3p, miR‐145‐3p/5p, miR‐19a‐3p, miR‐34c‐5p, miR‐3607‐3p, miR‐378e, miR‐671‐3p, and miR‐671‐5p) and 1 downregulated DEmiRNA (miR‐671‐3p/5p)), as well as 8 DEmiRNAs with a different expression pattern (i.e., miR‐1273g‐3p, miR‐146a‐5p, miR‐146b‐5p, miR‐337‐3p, miR‐382‐3p, miR‐4508, miR‐4516, and miR‐6087). Several signaling pathways (TNF, mTOR, Hippo, neutrophin, and pathways regulating pluripotency of stem cells), transcription factors (RUNX1, FOXA1, HIF1A, and MYC), and small molecule drugs (curcumin, docosahexaenoic acid (DHA), vitamin D3, arsenic trioxide, 5‐fluorouracil (5‐FU), and naringin) were identified as common regulators of both the DPSC and BMSC osteodifferentiation. Conclusion. Common genetic and epigenetic mechanisms are involved in the osteodifferentiation of DPSCs and BMSCs.